Evidence map›Paper›PMID 31907284›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses.

Patricia A Blundell, Dongli Lu, Anne Dell, Stuart Haslam, Richard J Pleass

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. ThePolymers · 2024
    Review
  7. Article
  8. Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.Biochimica et biophysica acta. General subjects · 2023
    Review
  9. Review
  10. Article
  11. ReliableMolecules (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. IgE Antibodies against Cancer: Efficacy and Safety.Antibodies (Basel, Switzerland) · 2020
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Patricia A BlundellDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom; and.ORCID 0000-0003-3386-5660
Dongli LuDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Anne DellDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Stuart HaslamDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0002-5563-679X
Richard J PleassDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom; and richard.pleass@lstmed.ac.uk.ORCID 0000-0001-7438-8296
Imperial College London · GBLiverpool School of Tropical Medicine · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F008309/1Biotechnology and Biological Sciences Research Council BBF0083091Medical Research Council MC_PC_16078Medical Research Council MC_PC_17167Wellcome Trust 097830/Z/11/ZWellcome Trust 109469/Z/15/ZWellcome Trust 208938/Z/17/Z
6 · The paper itself

Abstract

Abs are glycoproteins that carry a conserved

Indexed as

AnimalsAntibody SpecificityCHO CellsCricetinaeCricetulusGlycoproteinsGlycosylationHEK293 CellsHumansImmunoglobulin Fc FragmentsImmunoglobulin GInfluenza B virusInfluenza, HumanGlycoproteinsglycosylated IgGImmunoglobulin Fc FragmentsImmunoglobulin G

Identifiers

PMID31907284
PMCPMC6994840
OpenAlexW2999940487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.